CompletedNCT03525613
A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
PHASE3 · 637 planned enrolment
- Countries listed
- 14
- Registry update
- July 6, 2023
